Main Session: New Drugs and Novel Mechanisms of Action in Treating Patients with Multiple Myeloma

What are the mechanisms of action of the new and emerging agents for multiple myeloma?

Jonathan Kaufman, MD
The Winship Cancer Institute of Emory University


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here